EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Only a partial shield: local vancomycin postpones but does not prevent hip and knee prosthetic infections

Alexander Darup, Max Ettinger, Peter Savov, Sephan Brand, Gesine H Seeber, Ricarda Stauss

Archives of Orthopaedic and Trauma Surgery · 2026

DOI: 10.1007/s00402-026-06289-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Orthopaedic and Trauma Surgery, 2026. Verfasst von Alexander Darup und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Orthopaedics at Campus Pius-Hospital, Carl von Ossietzky University Oldenburg, School of Medicine and Health Sciences, Oldenburg, Germany…. Hauptthemen laut MEDLINE: Vancomycin, Prosthesis-Related Infections, Anti-Bacterial Agents, Arthroplasty, Replacement, Hip. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Carl von Ossietzky Universität Oldenburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Periprosthetic joint infection (PJI) represents a severe complication following total hip arthroplasty (THA) and total knee arthroplasty (TKA). The intraarticular application of vancomycin powder is increasingly integrated into perioperative standards as an innovative strategy for PJI prevention. Yet the efficacy of this method remains a topic of debate. The aim of this retrospective cohort study was to evaluate whether topical vancomycin application reduces the incidence of PJI after primary total joint arthroplasty (TJA) and whether it is associated with an increased risk of wound complications. Materials and methods In this retrospective monocentric cohort study, all primary THA and TKA procedures performed between January 1, 2022, and December 31, 2023, were analysed. From January 1, 2023, intraarticular vancomycin powder was implemented as part of the standard perioperative protocol for PJI prevention. The PJI rates, postoperative surgery-related complications, and time to infection were compared between the vancomycin and control groups.

Results

A total of 1,499 patients were included in the study. Patients were divided into two groups: a vancomycin group (VG, n = 818) and a control group (CG, n = 681). No statistically significant group differences were observed for wound healing disorders ( p = 0.775) or PJI rates (1.0% VG vs. 0.9% CG, p = 0.846). However, there was a statistically significant delay in the onset of infection in the VG compared to the CG (41.5 vs. 16.5 days, p = 0.006).

Conclusion

Intraarticular application of vancomycin powder was not associated with a reduction in overall PJI rates after primary TJA but appeared to be associated with a longer time to infection. These findings may suggest that local vancomycin application delays the clinical manifestation of infection rather than preventing it, potentially complicating the diagnosis of PJI and limiting less invasive treatment options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinProsthesis-Related InfectionsAnti-Bacterial AgentsArthroplasty, Replacement, HipArthroplasty, Replacement, KneeAntibiotic ProphylaxisHip ProsthesisKnee ProsthesisHumansRetrospective StudiesFemaleMaleAgedMiddle AgedAged, 80 and overAdministration, Topical

Stichwörter der Autor:innen

Periprosthetic joint infectionTotal hip arthroplastyTotal knee arthroplastyVancomycin powder

Substanzen

VancomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Orthopaedics at Campus Pius-Hospital, Carl von Ossietzky University Oldenburg, School of Medicine and Health Sciences, Oldenburg, Germany. Alexander.Darup@pius-hospital.de.
  • Division of Orthopaedics at Campus Pius-Hospital, Carl von Ossietzky University Oldenburg, School of Medicine and Health Sciences, Oldenburg, Germany.

Förderung

  • Carl von Ossietzky Universität Oldenburg

Zitieren

APA

Darup, A., Ettinger, M., Savov, P., Brand, S., Seeber, G. H., & Stauss, R. (2026). Only a partial shield: local vancomycin postpones but does not prevent hip and knee prosthetic infections. Archives of Orthopaedic and Trauma Surgery. https://doi.org/10.1007/s00402-026-06289-1

Vancouver

Darup A, Ettinger M, Savov P, Brand S, Seeber GH, Stauss R. Only a partial shield: local vancomycin postpones but does not prevent hip and knee prosthetic infections. Archives of Orthopaedic and Trauma Surgery. 2026. doi:10.1007/s00402-026-06289-1

BibTeX
@article{Darup2026,
  author = {Darup, Alexander and Ettinger, Max and Savov, Peter and Brand, Sephan and Seeber, Gesine H and Stauss, Ricarda},
  title = {Only a partial shield: local vancomycin postpones but does not prevent hip and knee prosthetic infections},
  journal = {Archives of Orthopaedic and Trauma Surgery},
  year = {2026},
  doi = {10.1007/s00402-026-06289-1}
}
Kostenlos starten →